ArticleTherapeutic advances in ophthalmology

Brolucizumab for persistent macular fluid in neovascular age-related macular degeneration after prior anti-VEGF treatments.

Rehan M Hussain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.